Diabetes News

CHICAGO — A small cohort of adults with obesity and prediabetes had lower glucose elevations and spent less time above range when they ate most of their calories before 1 p.m. compared with a more typical, later eating pattern.

CHICAGO — Children with diabetes and their caregivers use a wide variety of continuous glucose monitoring alarm settings, and usage may differ based on the child’s age, according to a presenter at ENDO 2023.

When Mihail Zilbermint, MD, MBA, was accepted to music school to become a classical singer, his mentor asked him if he was possibly interested in any other career.

CHICAGO — Older men with hypogonadism and high risk for cardiovascular disease who received testosterone therapy had similar rates of CV events as those who received placebo, according to findings from the TRAVERSE trial.

PHILADELPHIA — In this Healio video exclusive, Mikhail Kosiborod, MD, FACC, FAHA, co-chair of the Heart in Diabetes CME Conference, discusses the accomplishments of the meeting.

Mitchell A. Lazar, MD, PhD, has always been interested in organic chemistry, biochemistry and mental illness, which led him to delve into research on the regulation of gene expression in response to hormones, metabolites and drugs.

CHICAGO — Health care providers, institutions and facilities all have roles in reducing global warming and reversing effects of climate change, according to two plenary speakers at ENDO 2023.

R. Scott Struthers, PhD, had a lab job synthesizing peptide hormones as a college freshman. That experience launched a career featuring discovery of novel agents for endocrine diseases, women’s health conditions and cancers.

Experts from across the field of endocrinology will converge on Chicago beginning Thursday for the 2023 Endocrine Society annual meeting.

Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, may improve CV risk among patients with type 2 diabetes and kidney disease and those with albuminuria, according to a FIDELITY substudy published in JAMA Cardiology.